17th Annual NATA Symposium

16th Annual NATA Symposium, Prague 2015The 17th Annual NATA Symposium on Patient Blood Management, Haemostasis and Thrombosis will take place at the Royal Dublin Society in Dublin, Republic of Ireland, on April 14-15, 2016.

The deadline for abstract submission is December 18, 2015. Please click here to download an abstract submission form.

More information will be posted on Nataonline shortly.

Follow NATA on LinkedIn and Twitter

Join NATA's group on LinkedIn and follow NATA on Twitter (@NATAforum) to receive the latest news on patient blood management, haemostasis and thrombosis, and to participate in discussions with colleagues in the field.
LinkedIn Group / Twitter

Slide Presentations from the 16th Annual NATA Symposium, Prague, 2015

We are pleased to provide NATA members with PDF versions of presentations delivered at past NATA symposia. These presentations are made available for NATA members with permission from the authors and may have been modified to remove unpublished or copyrighted material.

To access presentations from the 16th Annual NATA Symposium, which was held in Prague on April 16-17, 2015, please log-in and go to the "Members' Area" section or click on the link below.
Slide Presentations from the 16th Annual NATA Symposium

News

Anaesthesia Supplement on ‘Transfusion, Thrombosis and Management of Bleeding’

Anaesthesia, the journal of the Association of Anaesthetists of Great Britain & Ireland, announces the publication of a special open-access supplement on Transfusion, Thrombosis and Management of Bleeding, to coincide with the UK launch of Patient Blood Management in the NHS.

A collaboration between anaesthetists, haematologists, surgeons and others, this supplement pulls together state-of-the-art research and recommendations into a comprehensive guide. World-renowned specialists have contributed a series of detailed reviews and debates.
Read more on this

From the Literature

Aug 28, 2015

Published: Aug 2015

Pollack CV, Jr., Reilly PA, Eikelboom J, et al.

Idarucizumab for dabigatran reversal.
N Engl J Med 2015;373:511-520.

#

NATA REVIEW:
Dabigatran etexilate, a direct thrombin inhibitor, has been increasingly used over the last few years, but the...
REVIEW by:
D. Faraoni

Published: Aug 2015

Glund S, Stangier J, Schmohl M, et al.

Safety, tolerability, and efficacy of idarucizumab for the reversal of the anticoagulant effect of dabigatran in healthy male volunteers: a randomised, placebo-controlled, double-blind phase 1 trial.
Lancet 2015;386:680-690.

#

NATA REVIEW:
Dabigatran etexilate is a direct thrombin inhibitor increasingly used for stroke prevention in patients with...
REVIEW by:
D. Faraoni

Published: Aug 2015

Butler CE, Noel S, Hibbs SP, et al.

Implementation of a clinical decision support system improves compliance with restrictive transfusion policies in hematology patients.
Transfusion 2015;55:1964-1971.

#

NATA REVIEW:
The authors report the impact of a clinical decision support system at a single centre to improve transfusion...
REVIEW by:
L. T. Goodnough

Published: Jul 2015

Barty RL, Gagliardi K, Owens W, et al.

A benchmarking program to reduce red blood cell outdating: implementation, evaluation, and a conceptual framework.
Transfusion 2015;55:1621-1627.

#

NATA REVIEW:
Outdating of blood components is a matter of concern in transfusion medicine. In the present study, a benchmarking...
REVIEW by:
R. Moog

Published: Jul 2015

Clark NP, Witt DM, Davies LE, et al.

Bleeding, recurrent venous thromboembolism, and mortality risks during warfarin interruption for invasive procedures.
JAMA Intern Med 2015;175:1163-1168.

#

NATA REVIEW:
Preoperative management of patients treated with vitamin K antagonists who require elective surgical procedures...
REVIEW by:
D. Faraoni

Published: Jul 2015

Parry-Jones AR, Di Napoli M, Goldstein JN, et al.

Reversal strategies for vitamin K antagonists in acute intracerebral hemorrhage.
Ann Neurol 2015;78:54-62.

#

NATA REVIEW:
Intracerebral haemorrhage is the most dreaded complication of anticoagulant treatment with vitamin K antagonists....
REVIEW by:
M. Levi